Reyvow

Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Fri, 09/11/20 - 12:11 pm
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Docs 'excited' to learn more about new migraine drugs from Biohaven, Lilly and AbbVie: analyst
Fierce Pharma
Thu, 06/25/20 - 10:53 am
migraines
physicians
Biohaven
Eli Lilly
AbbVie
Nurtec ODT
Ubrelvy
Reyvow
Reyvow, Migraine Drug That Treats Pain In Hours, Now Hits The Shelves
Forbes
Sat, 02/29/20 - 06:50 pm
Reyvow
migraines
drug launches
Eli Lilly
Lilly's migraine reliever Reyvow cleared for launch, beating Allergan's rival Ubrelvy to market
Fierce Pharma
Fri, 01/31/20 - 12:14 pm
migraines
Eli Lilly
Reyvow
Allergan
Ubrelvy
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
Xconomy
Fri, 10/11/19 - 10:50 pm
Eli Lilly
migraines
Lasmiditan
FDA
Reyvow